How does this service compare to standard transcriptomics?

Standard RNA-seq provides a static list of correlated gene changes. Our service goes further: by integrating the targeted pathway disruption step with multi-omic data, we establish causal relationships. This yields a directional GRN model, which is essential for predicting the outcome of your drug intervention, not just observing its immediate effect.

What specific data is generated to prove that pathway crosstalk has been resolved?

We use integrated epigenomic and proteomic data to validate transcription factor activity alongside changes in gene expression. For example, if you target Sirtuins, we quantify the change in FOXO1 deacetylation and map its binding sites, proving the regulatory link to IIS signaling at the molecular level. This level of detail ensures the most accurate predictions.

Key Signaling Pathway Disruption based Longevity Gene Regulatory Network (GRN) Validation Service

Creative Biolabs offers a non-negotiable solution for any therapeutic program targeting the biology of aging. What we provide is a high-resolution, dynamic map of your drug's precise effects, built upon rigorous perturbation science and integrated multi-omic data. What clients can expect to gain is definitive proof of mechanism, molecular resolution of pathway crosstalk (e.g., Sirtuin-FOXO1), and quantitative liability profiling that transforms high-risk candidates into validated, de-risked therapeutic blueprints, dramatically accelerating discovery timelines.

Introduction What We Can Offer Workflow Why Creative Biolabs Customer Reviews FAQs Related Services Contact Us

Validation of Longevity GRN through Pathway Disruption

Aging is a complex, transcriptionally regulated process driven by the failure of interconnected systems. The need for the key signaling pathway disruption based longevity GRN validation service arises because simple differential gene expression fails to account for the dynamic, non-linear interactions and cross-talk between metabolic sensors. We have built our approach on the established scientific principle that robust gene regulatory networks (GRNs) must be defined through perturbation-based causal mapping. This methodology resolves the regulatory loops between core pathways like IIS/mTOR and Sirtuin/AMPK, delivering high-confidence targets that have been functionally validated against detrimental aging phenotypes like SASP.

Initiate a dialogue: submit a consultation request for a comprehensive project assessment.

Fig 1. The Insulin/IGF-1 signaling pathway in C. elegans. (OA Literature)

Fig.1 Major longevity pathways and longevity-associated transcription factors in C. elegans. ¹

What We Can Offer

Ultimate Causal Mapping

We move beyond correlative data to build a functionally directional GRN using our advanced perturbation-based methodology, providing the definitive proof of mechanism required for high-stakes decisions like mechanism substantiation.

Molecular Resolution of Pathway Crosstalk

Creative Biolabs specializes in resolving the integrated signaling loops that govern aging, quantifying the precise regulatory interactions between core pathways (IIS/mTOR, Sirtuin/FOXO1, AMPK/SASP convergence) to ensure your intervention is harmonized, not disruptive.

Quantitative Pleiotropy and Liability Profiling

We utilize predictive systems biology models to identify, quantify, and map potential adverse off-target effects across the entire GRN, giving you a comprehensive safety overview long before expensive in vivo validation.

Adaptable Multi-Omics Strategy

We customize the required data input (transcriptomics, epigenomics, proteomics) and the appropriate high-resolution technique (scRNA-seq, ATAC-seq, etc.) based entirely on your target, model system, and therapeutic goal.

How We Can Help

Highlights

Causal Mapping Expertise

We employ a proven, perturbation-based methodology - a gold standard in developmental biology - directly adapted to aging. We don't just find correlation; we define causation.

Molecular Resolution of Crosstalk

We specialize in modeling the dynamic interaction between primary longevity pathways (IIS, mTOR, Sirtuins, AMPK), resolving critical events like the Sirtuin-mediated deacetylation of FOXO1 and the convergence of IIS/AMPK on SASP.

Predictive Power

Our GRN models are built using integrated multi-omics (transcriptomics, epigenomics, proteomics, post-translational modification data) to provide superior predictive power over standard transcriptomic screening.

Focus on Lifespan

Our analysis prioritizes mapping effects onto relevant endpoints like the senescence-associated secretory phenotype, ensuring your targets address functional decline, not just statistical lifespan extension.

Customer Reviews

FAQs

Related Services

Longevity Gene related Biomarker Monitoring

A specialized offering for tracking the efficacy of longevity interventions in model systems. This service focuses on high-precision quantification of validated aging and lifespan biomarkers derived from the GRN validation process, providing quantitative evidence of therapeutic impact.

Learn More →

Longevity Targeted Genetic Modulation

Provides specialized engineering of precise genetic tools in client-specified model systems to enable the necessary targeted pathway disruption required for GRN validation. This service ensures experimental control over key regulatory genes before compound testing.